177 related articles for article (PubMed ID: 8363121)
1. An introduction to the use of interim data analyses in clinical trials.
Lewis RJ
Ann Emerg Med; 1993 Sep; 22(9):1463-9. PubMed ID: 8363121
[TBL] [Abstract][Full Text] [Related]
2. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
3. Information time scales for interim analyses of randomized clinical trials.
Freidlin B; Othus M; Korn EL
Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947
[TBL] [Abstract][Full Text] [Related]
4. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
Chen YH; Li C; Lan KK
Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
[TBL] [Abstract][Full Text] [Related]
5. Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis.
Smith CL; Jin Y; Raddad E; McNearney TA; Ni X; Monteith D; Brown R; Deeg MA; Schnitzer T
Pharm Stat; 2019 Jan; 18(1):39-53. PubMed ID: 30321909
[TBL] [Abstract][Full Text] [Related]
6. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
Walter SD; Han H; Briel M; Guyatt GH
Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
[TBL] [Abstract][Full Text] [Related]
7. Self-designing trial combined with classical group sequential monitoring.
Yin G; Shen Y
J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
[TBL] [Abstract][Full Text] [Related]
8. [When is enough evidence available?; interim analyses in clinical trials].
van der Tweel Iv; Roes KC
Ned Tijdschr Geneeskd; 2013; 157(12):A5660. PubMed ID: 23515039
[TBL] [Abstract][Full Text] [Related]
9. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
10. An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.
Heritier S; Lô SN; Morgan CC
Stat Med; 2011 Jun; 30(13):1541-54. PubMed ID: 21432887
[TBL] [Abstract][Full Text] [Related]
11. Optimal timing for interim analyses in clinical trials.
Togo K; Iwasaki M
J Biopharm Stat; 2013; 23(5):1067-80. PubMed ID: 23957516
[TBL] [Abstract][Full Text] [Related]
12. Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses.
Gu M; Lai TL
Control Clin Trials; 1999 Oct; 20(5):423-38. PubMed ID: 10503802
[TBL] [Abstract][Full Text] [Related]
13. Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data.
Harden M; Friede T
Biom J; 2020 Sep; 62(5):1284-1299. PubMed ID: 32128868
[TBL] [Abstract][Full Text] [Related]
14. Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.
Shimura M; Maruo K; Gosho M
Pharm Stat; 2018 Sep; 17(5):400-413. PubMed ID: 29687592
[TBL] [Abstract][Full Text] [Related]
15. Increasing the sample size when the unblinded interim result is promising.
Chen YH; DeMets DL; Lan KK
Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
[TBL] [Abstract][Full Text] [Related]
16. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
Shimura M; Gosho M; Hirakawa A
Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
[TBL] [Abstract][Full Text] [Related]
17. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
18. A model for the interim analysis process: a case study.
Delgado-Herrera L; Anbar D
Control Clin Trials; 2003 Feb; 24(1):51-65. PubMed ID: 12559642
[TBL] [Abstract][Full Text] [Related]
19. Bayesian predictive probabilities: a good way to monitor clinical trials.
Ferreira D; Ludes PO; Diemunsch P; Noll E; Torp KD; Meyer N
Br J Anaesth; 2021 Feb; 126(2):550-555. PubMed ID: 33129491
[TBL] [Abstract][Full Text] [Related]
20. Stopping guidelines for clinical trials with multiple treatments.
Hughes MD
Stat Med; 1993 May; 12(10):901-15. PubMed ID: 8337547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
